Testing effectiveness (Phase 2)Study completedNCT03900715
What this trial is testing
An Efficacy and Safety Study of Luspatercept (ACE-536) for the Treatment of Anemia Due to IPSS-R Very Low, Low or Intermediate Risk Myelodysplastic Syndromes (MDS) in Japanese Subjects Who Are Not Requiring Red Blood Cell Transfusion
Who this might be right for
Myelodysplastic Syndromes
Celgene 21